Donations menu

You are here

News & Stories

Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Pharmaceutical company Chemo Group announced today that it will make a drug to treat the neglected tropical disease Chagas available to people in the United States. The U.S. Food and Drug Administration’s approval of the drug, benznidazole, means that Chagas pediatric patients in the U.S. could receive access to a therapy that Doctors Without Borders/Médecins Sans Frontières (MSF) has been using for decades to treat people living with Chagas across Latin America.

NEW YORK, DECEMBER 20, 2016—After 14 years of Chagas diagnoses, treatment and prevention efforts in Bolivia, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) ended its Chagas operations today by presenting Bolivia’s Ministry of Health with an operating manual for managing Chagas disease in rural areas.

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is concerned with the recent announcement that KaloBios has acquired rights to benznidazole, the drug MSF uses to treat Chagas disease in Latin America. KaloBios has announced its intent to register the drug in the United States to obtain a U.S. Federal Drug Administration (FDA) Priority Review Voucher (PRV), and then charge a high price.

SUCRE, BOLIVIA/NEW YORK—Doctors Without Borders/Médecins Sans Frontières (MSF) is launching a new project to ensure that people can be diagnosed and treated for Chagas disease in the town of Monteagudo, in the Chuquisaca department of southern Bolivia. In partnership with local health care institutions, the international medical humanitarian organization will develop a comprehensive care model for primary and secondary care that will be integrated into the existing health care system.

Chagas disease is a deadly parasitic disease rife throughout Latin America. Since Doctors Without Borders/Médecins Sans Frontières (MSF) and the health authorities instituted a treatment program, 43,000 people in Oaxaca State now have access to care for the disease.

Chagas disease is a parasitic illness transmitted by the bite of the vinchuca bug; it is found almost exclusively in the Americas. Without treatment, Chagas can eventually progress to fatally damaging the heart, and the nervous and digestive systems. A neglected disease, many people never learn that they have Chagas. Those who do face onerous treatment - there has been little research and development for better drugs.

Chagas is a neglected disease that affects between eight and ten million people, mainly in Latin America. Doctors Without Borders/Médecins Sans Frontières (MSF) works in Paraguay's rural Chaco region, going into isolated communities to educate people about the disease and screen them for it. Internationally, MSF fights to improve access to diagnosis and treatment for the disease and advocates for more research and development into its treatment.